Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00058
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Role of the Immune System in the Peritoneal Tumor Spread of High Grade Serous Ovarian Cancer

Oncotarget
Oncology
2016English

New in High Grade Serous Ovarian Cancer Treatment

Effective Pharmacotherapy
2019English

PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma

Journal of Oncology
Oncology
2010English

Total Pelvic Peritonectomy for Ovarian Cancer With Extensive Peritoneal Carcinomatosis in Pelvic Cavity

Gynecologic Oncology
GynecologyOncologyObstetrics
2019English

Targeting IDH1 as a Pro-Senescent Therapy in High-Grade Serous Ovarian Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

CDK4/6 Inhibition as Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer

Oncotarget
Oncology
2018English

Predictors of Long-Term Survival Among High-Grade Serous Ovarian Cancer Patients

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Low-Stage High-Grade Serous Ovarian Carcinomas

International Journal of Gynecological Pathology
GynecologyForensic MedicinePathologyObstetrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy